Brian Andreoli is a Partner at Duane Morris LLC.  Prior to joining Duane Morris Brian was a principal with Ernst & Young in the International Tax Services practice, with a specialty in transfer pricing.  Based on his 18 years experience in the pharmaceutical industry, he also advises clients on a variety of pharmaceutical tax issues including state, federal and international tax planning issues and assisting in federal and state tax audits.  Brian advises both U.S. owned and foreign owned pharmaceutical and biotech companies, as well as companies in other industries.  Prior to joining Ernst & Young, Brian was the Director of Tax /Tax Counsel and Director of Risk Management at a major pharmaceutical company.  As a member of Tax Executive Institute, he served on both the International Tax Committee and the State Tax Committee.  He was also Chairman of the Possessions Corporation Committee.  As a member of the Pharmaceutical Research Manufacturers' Association tax committee, he was chairman of the state tax committee.  He is experienced in handling international tax audit issues as well as other issues concerning the pharmaceutical industry. He has designed and defended on audit, cost sharing agreements, royalty agreements and intercompany services.  He successfully led several pharmaceutical industry coalitions to pass state tax legislation.  In addition, he argued state tax cases at administrative hearings, court proceedings and pursued court appeals.  Most notable were decisions concerning nexus, unitary tax, state combined group filings, sales tax issues involving samples, services and purchases.  Brian is both a CPA (New York) and an attorney (New York, Massachusetts, Connecticut and the District of Columbia). .  He is a frequent lecturer on transfer pricing and state tax issues.   Brian holds a BA from Franklin and Marshall College in Government, an MBA in Accounting from New York University, a JD from Fordham University and a LLM in Business and Taxation from Quinnipiac University School of Law.